These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

751 related articles for article (PubMed ID: 16222300)

  • 1. Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells.
    Fujiwara T; Bandi M; Nitta M; Ivanova EV; Bronson RT; Pellman D
    Nature; 2005 Oct; 437(7061):1043-7. PubMed ID: 16222300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 represses the polyploidization of primary mammary epithelial cells by activating apoptosis.
    Senovilla L; Vitale I; Galluzzi L; Vivet S; Joza N; Younes AB; Rello-Varona S; Castedo M; Kroemer G
    Cell Cycle; 2009 May; 8(9):1380-5. PubMed ID: 19342895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
    Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
    Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone-induced chromosomal instability in p53-null mammary epithelium.
    Pati D; Haddad BR; Haegele A; Thompson H; Kittrell FS; Shepard A; Montagna C; Zhang N; Ge G; Otta SK; McCarthy M; Ullrich RL; Medina D
    Cancer Res; 2004 Aug; 64(16):5608-16. PubMed ID: 15313898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone facilitates chromosome instability (aneuploidy) in p53 null normal mammary epithelial cells.
    Goepfert TM; McCarthy M; Kittrell FS; Stephens C; Ullrich RL; Brinkley BR; Medina D
    FASEB J; 2000 Nov; 14(14):2221-9. PubMed ID: 11053243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of cellular and genetic drivers of breast cancer heterogeneity in genetically engineered mouse tumour models.
    Melchor L; Molyneux G; Mackay A; Magnay FA; Atienza M; Kendrick H; Nava-Rodrigues D; López-García MÁ; Milanezi F; Greenow K; Robertson D; Palacios J; Reis-Filho JS; Smalley MJ
    J Pathol; 2014 Jun; 233(2):124-37. PubMed ID: 24615332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetraploid cells produced by absence of substrate adhesion during cytokinesis are limited in their proliferation and enter senescence after DNA replication.
    De Santis Puzzonia M; Gonzalez L; Ascenzi S; Cundari E; Degrassi F
    Cell Cycle; 2016; 15(2):274-82. PubMed ID: 26693937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetraploid cells from cytokinesis failure induce aneuploidy and spontaneous transformation of mouse ovarian surface epithelial cells.
    Lv L; Zhang T; Yi Q; Huang Y; Wang Z; Hou H; Zhang H; Zheng W; Hao Q; Guo Z; Cooke HJ; Shi Q
    Cell Cycle; 2012 Aug; 11(15):2864-75. PubMed ID: 22801546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A gain of function p53 mutant promotes both genomic instability and cell survival in a novel p53-null mammary epithelial cell model.
    Murphy KL; Dennis AP; Rosen JM
    FASEB J; 2000 Nov; 14(14):2291-302. PubMed ID: 11053251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptome analysis of tetraploid cells identifies cyclin D2 as a facilitator of adaptation to genome doubling in the presence of p53.
    Potapova TA; Seidel CW; Box AC; Rancati G; Li R
    Mol Biol Cell; 2016 Oct; 27(20):3065-3084. PubMed ID: 27559130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation.
    Xu X; Wagner KU; Larson D; Weaver Z; Li C; Ried T; Hennighausen L; Wynshaw-Boris A; Deng CX
    Nat Genet; 1999 May; 22(1):37-43. PubMed ID: 10319859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
    McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
    Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deregulated Aurora-B induced tetraploidy promotes tumorigenesis.
    Nguyen HG; Makitalo M; Yang D; Chinnappan D; St Hilaire C; Ravid K
    FASEB J; 2009 Aug; 23(8):2741-8. PubMed ID: 19332642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetraploidy, aneuploidy and cancer.
    Ganem NJ; Storchova Z; Pellman D
    Curr Opin Genet Dev; 2007 Apr; 17(2):157-62. PubMed ID: 17324569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pubertal and adult windows of susceptibility to a high animal fat diet in Trp53-null mammary tumorigenesis.
    Zhu Y; Aupperlee MD; Zhao Y; Tan YS; Kirk EL; Sun X; Troester MA; Schwartz RC; Haslam SZ
    Oncotarget; 2016 Dec; 7(50):83409-83423. PubMed ID: 27825136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The requirement of p53 for maintaining chromosomal stability during tetraploidization.
    Ho CC; Hau PM; Marxer M; Poon RYC
    Oncotarget; 2010 Nov; 1(7):583-595. PubMed ID: 21317454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reprogramming of the estrogen responsive transcriptome contributes to tamoxifen-dependent protection against tumorigenesis in the p53 null mammary epithelial cells.
    Palaniappan M; Edwards D; Creighton CJ; Medina D; Conneely OM
    PLoS One; 2018; 13(3):e0194913. PubMed ID: 29590203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multipolar mitosis of tetraploid cells: inhibition by p53 and dependency on Mos.
    Vitale I; Senovilla L; Jemaà M; Michaud M; Galluzzi L; Kepp O; Nanty L; Criollo A; Rello-Varona S; Manic G; Métivier D; Vivet S; Tajeddine N; Joza N; Valent A; Castedo M; Kroemer G
    EMBO J; 2010 Apr; 29(7):1272-84. PubMed ID: 20186124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The DNA resection protein CtIP promotes mammary tumorigenesis.
    Reczek CR; Shakya R; Miteva Y; Szabolcs M; Ludwig T; Baer R
    Oncotarget; 2016 May; 7(22):32172-83. PubMed ID: 27058754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Illicit survival of cancer cells during polyploidization and depolyploidization.
    Vitale I; Galluzzi L; Senovilla L; Criollo A; Jemaà M; Castedo M; Kroemer G
    Cell Death Differ; 2011 Sep; 18(9):1403-13. PubMed ID: 21072053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.